T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Vir Biotechnology
VIR
$1.52B
| $509K | ﹤0.01% |
67,826
+9,983
| +17% | +$86.7K |
|
2227
Gray Television
GTN
$520M
| $508K | ﹤0.01% |
94,631
+715
| +0.8% | +$3.68K |
|
2228
MVB Financial
MVBF
$397M
| $508K | ﹤0.01% |
26,231
+368
| +1% | +$7.63K |
|
2229
IDT Corp
IDT
$1.67B
| $507K | ﹤0.01% |
13,267
+178
| +1% | +$6.61K |
|
2230
Tecnoglass Holdings Inc.
TGLS
$1.87B
| $506K | ﹤0.01% |
+7,358
| New | +$427K |
|
|
RVNC
2231
DELISTED
Revance Therapeutics, Inc.
RVNC
| $499K | ﹤0.01% |
96,076
+1,623
| +2% | +$8.07K |
|
2232
Cass Information Systems
CASS
$750M
| $498K | ﹤0.01% |
11,999
-1,398
| -10% | -$57.9K |
|
2233
HealthStream
HSTM
$849M
| $498K | ﹤0.01% |
17,235
+260
| +2% | +$7.45K |
|
2234
Digital Turbine
APPS
$1.53B
| $497K | ﹤0.01% |
161,718
+4,821
| +3% | +$13K |
|
2235
Microvision
MVIS
$89.7M
| $495K | ﹤0.01% |
28,914
+9,761
| +51% | +$152K |
|
2236
Marten Transport
MRTN
$1.24B
| $493K | ﹤0.01% |
27,806
+713
| +3% | +$12.5K |
|
2237
Nuvation Bio
NUVB
$2.14B
| $493K | ﹤0.01% |
215,267
-5,052
| -2% | -$15.4K |
|
2238
GrafTech
EAF
$203M
| $492K | ﹤0.01% |
37,200
+16,230
| +77% | +$135K |
|
|
ACRE
2239
Ares Commercial Real Estate
ACRE
$264M
| $491K | ﹤0.01% |
70,134
+16,879
| +32% | +$121K |
|
2240
AvePoint
AVPT
$2.91B
| $491K | ﹤0.01% |
41,659
+1,386
| +3% | +$15.2K |
|
2241
iShares Core US Aggregate Bond ETF
AGG
$138B
| $489K | ﹤0.01% |
+4,820
| New | +$481K |
|
2242
Global Industrial
GIC
$1.49B
| $489K | ﹤0.01% |
14,390
+1,100
| +8% | +$36.2K |
|
2243
Liquidity Services
LQDT
$1.35B
| $489K | ﹤0.01% |
21,427
+412
| +2% | +$8.89K |
|
|
ADAM
2244
Adamas Trust
ADAM
$907M
| $489K | ﹤0.01% |
77,209
+813
| +1% | +$5.23K |
|
2245
DHT Holdings
DHT
$3.09B
| $487K | ﹤0.01% |
44,136
+1,223
| +3% | +$13.5K |
|
2246
Kearny Financial
KRNY
$604M
| $487K | ﹤0.01% |
70,851
| – | – |
|
2247
Levi Strauss
LEVI
$8.63B
| $487K | ﹤0.01% |
22,302
| – | – |
|
|
ONIT
2248
Onity Group
ONIT
$330M
| $487K | ﹤0.01% |
15,239
+3,000
| +25% | +$81.8K |
|
2249
Greenlight Captial
GLRE
$512M
| $485K | ﹤0.01% |
35,506
-4,801
| -12% | -$64K |
|
2250
American Superconductor
AMSC
$1.53B
| $484K | ﹤0.01% |
20,479
-7,300
| -26% | -$168K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.